187 related articles for article (PubMed ID: 32666213)
1. Correlates of cognitive impairment in adult cancer survivors who have received chemotherapy and report cognitive problems.
Gutenkunst SL; Vardy JL; Dhillon HM; Bell ML
Support Care Cancer; 2021 Mar; 29(3):1377-1386. PubMed ID: 32666213
[TBL] [Abstract][Full Text] [Related]
2. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
4. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy.
Dhillon HM; Tannock IF; Pond GR; Renton C; Rourke SB; Vardy JL
J Cancer Surviv; 2018 Apr; 12(2):178-185. PubMed ID: 29080061
[TBL] [Abstract][Full Text] [Related]
5. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
6. Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study.
van der Willik KD; Koppelmans V; Hauptmann M; Compter A; Ikram MA; Schagen SB
Breast Cancer Res; 2018 Nov; 20(1):135. PubMed ID: 30442190
[TBL] [Abstract][Full Text] [Related]
7. Subjective cognitive functioning and associations with psychological distress in adult brain tumour survivors.
Nicol C; Ownsworth T; Cubis L; Nguyen W; Foote M; Pinkham MB
J Cancer Surviv; 2019 Oct; 13(5):653-662. PubMed ID: 31313128
[TBL] [Abstract][Full Text] [Related]
8. Self-reported cognitive decline in Japanese patients with breast cancer treated with endocrine therapy.
Yamamoto S; Masutani E; Arao H
Breast Cancer; 2020 Jul; 27(4):670-682. PubMed ID: 32114664
[TBL] [Abstract][Full Text] [Related]
9. Cognitive complaints in cancer survivors and expectations for support: Results from a web-based survey.
Lange M; Licaj I; Clarisse B; Humbert X; Grellard JM; Tron L; Joly F
Cancer Med; 2019 May; 8(5):2654-2663. PubMed ID: 30884207
[TBL] [Abstract][Full Text] [Related]
10. Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns.
Apple AC; Ryals AJ; Alpert KI; Wagner LI; Shih PA; Dokucu M; Cella D; Penedo FJ; Voss JL; Wang L
Neuroimage Clin; 2017; 14():685-691. PubMed ID: 28377882
[TBL] [Abstract][Full Text] [Related]
11. Distinct and heterogeneous trajectories of self-perceived cognitive impairment among Asian breast cancer survivors.
Ng T; Dorajoo SR; Cheung YT; Lam YC; Yeo HL; Shwe M; Gan YX; Foo KM; Loh WK; Koo SL; Jain A; Lee GE; Dent R; Yap YS; Ng R; Chan A
Psychooncology; 2018 Apr; 27(4):1185-1192. PubMed ID: 29315963
[TBL] [Abstract][Full Text] [Related]
12. Cognition, quality-of-life, and symptom clusters in breast cancer: Using Bayesian networks to elucidate complex relationships.
Xu S; Thompson W; Ancoli-Israel S; Liu L; Palmer B; Natarajan L
Psychooncology; 2018 Mar; 27(3):802-809. PubMed ID: 29055062
[TBL] [Abstract][Full Text] [Related]
13. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer.
Vardy JL; Stouten-Kemperman MM; Pond G; Booth CM; Rourke SB; Dhillon HM; Dodd A; Crawley A; Tannock IF
Brain Imaging Behav; 2019 Feb; 13(1):15-26. PubMed ID: 28466438
[TBL] [Abstract][Full Text] [Related]
14. Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.
Smith A'; Sharpe L; Thewes B; Turner J; Gilchrist J; Fardell JE; Girgis A; Tesson S; Descallar J; Bell ML; Beith J; Butow P;
Support Care Cancer; 2018 Dec; 26(12):4207-4216. PubMed ID: 29882025
[TBL] [Abstract][Full Text] [Related]
15. Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study.
Vega JN; Albert KM; Mayer IA; Taylor WD; Newhouse PA
J Cancer Surviv; 2019 Oct; 13(5):673-686. PubMed ID: 31338732
[TBL] [Abstract][Full Text] [Related]
16. Testing a novel account of the dissociation between self-reported memory problems and memory performance in chemotherapy-treated breast cancer survivors.
Paquet L; Verma S; Collins B; Chinneck A; Bedard M; Song X
Psychooncology; 2018 Jan; 27(1):171-177. PubMed ID: 28129471
[TBL] [Abstract][Full Text] [Related]
17. Cognitive Perception among Post-Chemotherapy, Non-Chemotherapy Breast Cancer Survivors and Non-Cancer.
Syarif H; Waluyo A; Afiyanti Y
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1775-1780. PubMed ID: 34181333
[TBL] [Abstract][Full Text] [Related]
18. The chemo-gut study: investigating the long-term effects of chemotherapy on gut microbiota, metabolic, immune, psychological and cognitive parameters in young adult Cancer survivors; study protocol.
Deleemans JM; Chleilat F; Reimer RA; Henning JW; Baydoun M; Piedalue KA; McLennan A; Carlson LE
BMC Cancer; 2019 Dec; 19(1):1243. PubMed ID: 31870331
[TBL] [Abstract][Full Text] [Related]
19. Relationships between self-reported sleep quality components and cognitive functioning in breast cancer survivors up to 10 years following chemotherapy.
Henneghan AM; Carter P; Stuifbergan A; Parmelee B; Kesler S
Psychooncology; 2018 Aug; 27(8):1937-1943. PubMed ID: 29683228
[TBL] [Abstract][Full Text] [Related]
20. Subjective cognitive impairment and brain structural networks in Chinese gynaecological cancer survivors compared with age-matched controls: a cross-sectional study.
Zeng Y; Cheng ASK; Song T; Sheng X; Zhang Y; Liu X; Chan CCH
BMC Cancer; 2017 Nov; 17(1):796. PubMed ID: 29179739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
